Albany Molecular Research (AMRI) has signed a three-year manufacturing and supply agreement with UK-based technology development company Revolymer, which designs, develops and formulates polymers.
As per the deal, AMRI will be the primary manufacturer and supplier of Rev7, AGC and other polymers present in Rev7 degradable gum products.
The deal will be executed in response to the British Retail Consortium Global Standards for Food Safety and the recognised standards of good manufacturing practice.
AMRI chairman and CEO Thomas D'Ambra said they look forward to working with Revolymer as it develops and further expands its line of products.
